Bojang, K., Milligan, P., Pinder, M., Doherty, T., Leach, A., Ofori-Anyinam, O., . . . Cohen, J. (2009). Five-year safety and immunogenicity of GlaxoSmithKline’s candidate malaria vaccine RTS,S/AS02 following administration to semi-immune adult men living in a malaria-endemic region of The Gambia.
Citación estilo ChicagoBojang, Kalifa, et al. Five-year Safety and Immunogenicity of GlaxoSmithKline’s Candidate Malaria Vaccine RTS,S/AS02 Following Administration to Semi-immune Adult Men Living in a Malaria-endemic Region of The Gambia. 2009.
Cita MLABojang, Kalifa, et al. Five-year Safety and Immunogenicity of GlaxoSmithKline’s Candidate Malaria Vaccine RTS,S/AS02 Following Administration to Semi-immune Adult Men Living in a Malaria-endemic Region of The Gambia. 2009.